Canada - English - Health Canada

apotex inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 25mg - quetiapine (quetiapine fumarate) 25mg - atypical antipsychotics

Canada - English - Health Canada

apotex inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 100mg - quetiapine (quetiapine fumarate) 100mg - atypical antipsychotics

Canada - English - Health Canada

apotex inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics

Canada - English - Health Canada

apotex inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 300mg - quetiapine (quetiapine fumarate) 300mg - atypical antipsychotics

Canada - English - Health Canada

pharmapar inc - quetiapine (quetiapine fumarate) - tablet - 25mg - quetiapine (quetiapine fumarate) 25mg - atypical antipsychotics

Canada - English - Health Canada

pharmapar inc - quetiapine (quetiapine fumarate) - tablet - 100mg - quetiapine (quetiapine fumarate) 100mg - atypical antipsychotics

Canada - English - Health Canada

pharmapar inc - quetiapine (quetiapine fumarate) - tablet - 150mg - quetiapine (quetiapine fumarate) 150mg - atypical antipsychotics

Canada - English - Health Canada

pharmapar inc - quetiapine (quetiapine fumarate) - tablet - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics

Canada - English - Health Canada

pharmapar inc - quetiapine (quetiapine fumarate) - tablet - 300mg - quetiapine (quetiapine fumarate) 300mg - atypical antipsychotics

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine 50 mg - quetiapine tablet is indicated for the treatment of schizophrenia. the efficacy of quetiapine tablets in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13 to 17 years). the effectiveness of quetiapine tablets for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials [see clinical studies (14.1)]. quetiapine tablet is indicated for the acute treatment of manic episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. efficacy was established in two 12-week monotherapy trials in adults, in one 3-week adjunctive trial in adults, and in one 3-week monotherapy trial in pediatric patients (10 to 17 years) [ see clinical studies (14.2)] . quetiapine tablet is indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder. efficacy was established in two 8-week monotherapy trials in adult patients with bipolar i and b